Mirae Asset Global Investments’s Zimmer Biomet ZBH Stock Holding History

Mirae Asset Global Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.01M	Buy	46,629 +3,832	+9%	+$336K	0.01%	655
2026 Q1	$3.87M	Buy	42,797 +6,218	+17%	+$571K	﹤0.01%	605
2025 Q4	$3.29M	Buy	36,579 +6,495	+22%	+$616K	0.01%	668
2025 Q3	$2.96M	Buy	30,084 +3,172	+12%	+$314K	0.01%	646
2025 Q2	$2.45M	Buy	26,912 +1,971	+8%	+$191K	0.01%	643
2025 Q1	$2.8M	Buy	24,941 +2,785	+13%	+$298K	0.01%	582
2024 Q4	$2.36M	Buy	22,156 +4,645	+27%	+$498K	0.01%	613
2024 Q3	$1.9M	Buy	17,511 +3,633	+26%	+$396K	0.01%	651
2024 Q2	$1.5M	Sell	13,878 -38,336	-73%	-$4.52M	0.01%	652
2024 Q1	$6.67M	Buy	52,214 +3,682	+8%	+$460K	0.01%	810
2023 Q4	$5.91M	Sell	48,532 -7,819	-14%	-$872K	0.01%	835
2023 Q3	$6.32M	Buy	56,351 +7,591	+16%	+$964K	0.01%	790
2023 Q2	$7.1M	Buy	48,760 +1,096	+2%	+$149K	0.02%	794
2023 Q1	$6.16M	Buy	47,664 +6,879	+17%	+$864K	0.01%	808
2022 Q4	$5.2M	Sell	40,785 -3,610	-8%	-$419K	0.01%	813
2022 Q3	$4.64M	Sell	44,395 -2,833	-6%	-$311K	0.01%	827
2022 Q2	$4.96M	Buy	47,228 +6,280	+15%	+$745K	0.01%	841
2022 Q1	$5.24M	Buy	40,948 +4,689	+13%	+$565K	0.01%	863
2021 Q4	$4.47M	Sell	36,259 -5,161	-12%	-$675K	0.01%	915
2021 Q3	$5.89M	Buy	41,420 +14,681	+55%	+$2.16M	0.01%	800
2021 Q2	$4.17M	Buy	26,739 +19,959	+294%	+$3.23M	0.01%	855
2021 Q1	$1.05M	Sell	6,780 -19,115	-74%	-$2.96M	﹤0.01%	1116
2020 Q4	$3.87M	Buy	25,895 +1,980	+8%	+$280K	0.01%	721
2020 Q3	$3.16M	Buy	23,915 +8,810	+58%	+$1.15M	0.02%	653
2020 Q2	$1.75M	Buy	15,105 +1,205	+9%	+$139K	0.01%	739
2020 Q1	$1.36M	Buy	13,900 +409	+3%	+$53.6K	0.01%	746
2019 Q4	$1.96M	Buy	13,491 +1,640	+14%	+$226K	0.01%	753
2019 Q3	$1.58M	Buy	11,851 +1,017	+9%	+$131K	0.01%	770
2019 Q2	$1.24M	Sell	10,834 -478	-4%	-$56K	0.01%	841
2019 Q1	$1.4M	Sell	11,312 -28,179	-71%	-$3.2M	0.01%	730
2018 Q4	$3.98M	Sell	39,491 -9,117	-19%	-$1.03M	0.04%	421
2018 Q3	$6.2M	Buy	48,608 +35,925	+283%	+$4.27M	0.05%	367
2018 Q2	$1.37M	Buy	+12,683	New	+$1.38M	0.02%	450
2018 Q1	–	Sell	-13,046	Closed	-$1.53M	–	776
2017 Q4	$1.53M	Buy	13,046 +4,422	+51%	+$500K	0.02%	405
2017 Q3	$979K	Buy	+8,624	New	+$996K	0.02%	427
2017 Q1	–	Sell	-9,223	Closed	-$923K	–	670
2016 Q4	$923K	Sell	9,223 -1,692	-16%	-$181K	0.02%	336
2016 Q3	$1.38M	Buy	10,915 +718	+7%	+$88.7K	0.03%	286
2016 Q2	$1.19M	Buy	+10,197	New	+$1.15M	0.03%	297
2015 Q1	–	Sell	-10,783	Closed	-$1.19M	–	507
2014 Q4	$1.19M	Sell	10,783 -273	-2%	-$28.8K	0.04%	243
2014 Q3	$1.08M	Buy	11,056 +45	+0.4%	+$4.43K	0.04%	263
2014 Q2	$1.11M	Buy	+11,011	New	+$1.07M	0.02%	246

Other funds holding ZBH

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mirae Asset Global Investments's ZBH Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Zimmer Biomet (ZBH) stake by 9% in Q2 2026, buying an estimated $336K and bringing the position to 46,629 shares worth $4.01M. The position accounts for 0.01% of the portfolio, ranked #655.

Mirae Asset Global Investments first reported a position in ZBH in Q2 2014 and has held it in 41 quarters since. The position peaked at $7.1M in Q2 2023. 225 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Mirae Asset Global Investments held 46,629 shares of Zimmer Biomet worth $4.01M as of Q2 2026.
Mirae Asset Global Investments bought 3,832 Zimmer Biomet shares in Q2 2026, an estimated $336K.
Zimmer Biomet made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #655 holding.
Mirae Asset Global Investments first reported a position in Zimmer Biomet in Q2 2014 and has held it in 41 quarters since.
Mirae Asset Global Investments's Zimmer Biomet position peaked at $7.1M in Q2 2023.
225 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.